The first FLEXion-400 ion implanter, latest evolution of the new IBS FLEXion line of products, has been delivered to a major research institute in China and is fully operational since May 2018. The FLEXion line is the brand new generation of medium current ion implanters developed by IBS, and represents a leap forward in terms of productivity and performances compared to the IMC implanters. The FLEXion implanters are available in both 200 kV and 400 kV acceleration voltage and are fitted with a high selectivity analyzer magnet and IHC ion source. They are optimized to address volume production for SiC and III-V substrates markets.
Following the initial certification of its core ion implantation foundry service in 2006, IBS has continuously expanded its Quality policy towards all its service & manufacturing activities. Today, IBS is proud to confirm the success of this commitment by achieving the certification of all its business units under the ISO 9001-2015 norm. This recognition strengthens the position of IBS among the major implanter manufacturers.
IBS is glad to announce the order of its first ion implanter IMC-200 in India. This system is configured to perform implantations in a wide range of temperatures from 170K (-100°C) to 550°C thanks to the use of two specific platens developed by IBS.
This delivery comforts the choice of IBS to offer a R&D line of equipment (IMC) for high-end research applications and a brand-new line (FLEXion) for production of emerging technologies.
As the first Chinese IMC-200 ion implanter is now in production at Xi’An Jiaotong University, IBS enters a market that represents more than 75% of the yearly worldwide sales of advanced semiconductor equipments. With already 80% of IBS business made overseas, this sale is the first step towards IBS goal to double its turnover within the next 4 years in terms of equipment sales.
As the result of a strong collaboration between IBS and CEA (French Atomic Energy research center), the first IBS PULSION® SOLAR PIII system is fully operational at INES (National Institute for Solar Energy) research facilities since January 2017. The latest model of IBS PULSION® PIII systems, the PULSION® SOLAR implanter, addresses two main challenges of solar energy development: Cost of production for high yield photovoltaic cells, and improvement of their performances.
IBS announces a sale of its latest PULSION® HP tool 300mm immersion plasma tool. The purchase order was from an undisclosed leading semiconductor company in the USA. Moreover, IBS confirms the success of PULSION® Nano product line with the delivery of 3 new equipments.